Factors Influencing the Risk of Major Amputation in Patients with Diabetic Foot Ulcers Treated by Autologous Cell Therapy

Table 2

Classification systems of DFU at baseline and at all follow-up visits.

	AMP				nAMP
	Baseline; ()	1 M; ()	3 M; ()	6 M; ()	Baseline; ()	1 M; ()	3 M; ()	6 M; ()
Wagner (mean)	3.43	3.40	3.14	2.93	2.87	2.79	1.78	1.06
Wagner 3 (%)	6 (16%)	8 (23%)	8 (28%)	3 (21%)	7 (9%)	9 (38%)	5 (7%)	4 (6%)
Wagner 4 (%)	24 (65%)	21 (60%)	11 (38%)	4 (29%)	33 (43%)	30 (12%)	12 (17%)	4 (6%)
PEDIS infection	1.54	1.91	2.07	2.00	0.68	0.58	0.22	0.08
WIfI (mean)
Wound	1.81	1.91	2.00	1.93	1.93	1.84	1.74	0.86
Ischemia	2.95	2.49	2.31	1.93	2.97	2.20	1.74	1.48
Foot infection	0.57	0.91	1.07	1.00	0.64	0.47	0.19	0.07
TEXAS (%)
TEXAS B only infection	0 (0%)	1 (3%)	5 (17%)	1 (7%)	0 (0%)	0 (0%)	2 (3%)	2 (3%)
TEXAS C only ischemia	28 (76%)	14 (40%)	3 (10%)	4 (29%)	49 (64%)	33 (43%)	26 (36%)	20 (28%)
TEXAS D infection and ischemia	9 (24%)	17 (49%)	16 (55%)	5 (36%)	27 (36%)	27 (36%)	4 (6%)	1 (1%)